A water-damaged home and health of occupants

When a Home Gets Water-Damaged, the Occupants Become the “Sensors”

A water-damaged home is more than an inconvenient repair project. Once building materials stay wet long enough—especially drywall, insulation, carpeting, subflooring, or poorly ventilated cavities—the indoor environment can shift into a biologically active ecosystem. Mold can colonize. Bacteria can proliferate. And both can generate compounds that irritate or inflame the airways, trigger allergic disease, or worsen asthma and other respiratory conditions. Large evidence reviews consistently link indoor dampness and mold with higher rates of cough, wheeze, upper respiratory symptoms, allergic rhinitis, eczema, and asthma development or exacerbation.

What’s harder—and where the conversation often becomes controversial—is the role of “toxic by-products,” including mycotoxins and microbial fragments, in symptoms beyond the lungs, such as fatigue, headaches, mood changes, and cognitive complaints. The science here is active, nuanced, and frequently misunderstood: some experimental and observational studies suggest plausible pathways for systemic effects, while other work finds inconsistent or weak associations, especially when exposure is not well characterized.

To see how complex this can become in real life, consider the following published-style case narrative and what it teaches us about water-damaged buildings (WDB).


A Family of Five, a Dog, and a Water-Damaged Rental: A High-Resolution Look at Exposure

A family of five—and their pet dog—rented a home with clear signs of water damage. Over time, multiple family members developed a wide range of symptoms and eventually received several diagnoses, including chronic sinusitis, coughing with wheeze, nosebleeds, fatigue, and neurological deficits. The pattern raised a central question that comes up repeatedly in clinical practice and environmental health: could the indoor environment be contributing to illness, and if so, how do you prove it?

Instead of stopping at visual inspection or a simple air sample, the investigation went deep:

1) Building analysis: “What’s growing in the home?”

The home was analyzed for mold and bacterial species. Water-damaged materials can host mixed communities: fungi (like Aspergillus and Penicillium) and bacteria that thrive in wet niches. Dampness/mold exposure has a well-established relationship with respiratory symptoms and asthma outcomes at the population level, which supports taking building moisture seriously even before specific species are identified.

2) Clinical diagnostics: “What’s happening in the people?”

The medical workup included:

  • MRI and ENT evaluation for chronic sinusitis, with sinus surgery in at least one family member.
  • Neurological testing for neurocognitive deficits.

Chronic rhinosinusitis is a complex inflammatory condition with multiple “endotypes.” In some patients, fungi are implicated in noninvasive allergic fungal rhinosinusitis (AFRS) or related inflammatory pathways, and Aspergillus species—including A. fumigatus—are commonly discussed in this context.

3) Targeted toxin testing across multiple sample types

Bulk samples from the home and multiple human and animal specimens were tested for trichothecenes, aflatoxins, and ochratoxin A (OTA), including:

  • Human: tissue from sinuses, urine, nasal secretions, placenta, umbilical cord, and breast milk
  • Dog: skin lesions (sebaceous glands and lipomas)

Mycotoxins are real chemical compounds produced by certain fungi under certain conditions. But interpreting human testing is tricky: some mycotoxins also come from diet (contaminated grains, coffee, dried fruit, spices), and not every lab method is clinically validated for diagnosing “mold illness.” In fact, the CDC has cautioned that there is no FDA-approved urine test for mycotoxins for clinical diagnosis, and that results from some direct-to-consumer testing have uncertain clinical meaning.

That said, the striking element in this case narrative is the breadth of matrices testing positive: mycotoxins were reportedly detected not only in bulk building samples and urine/nasal secretions, but also in breast milk, placenta, and umbilical cord.

From the broader scientific literature, OTA has been repeatedly detected in human milk in multiple populations, and researchers have discussed its relevance for infant exposure.
There is also evidence in the literature that OTA can cross the placenta, with newer work examining associations between OTA status at birth and growth measures (context-dependent and not proof of causation for any single outcome).


Microbes Found in the Airways: Why Cultures and PCR Matter

In this family narrative, nasal secretions from the father and daughter grew:

  • Pseudomonas aeruginosa
  • Acinetobacter
  • Penicillium
  • Aspergillus fumigatus

Additionally, RT-PCR detected A. fumigatus DNA in the daughter’s sinus tissue.

This combination is important for two reasons:

  1. It ties symptoms to a relevant anatomical site. Chronic sinusitis is not an abstract diagnosis; it involves inflamed mucosa, impaired drainage, and sometimes biofilms or persistent microbial communities. Modern research into chronic rhinosinusitis highlights that both culture-based findings and sequencing/PCR can reveal organisms that may influence inflammation and outcomes.
  2. It demonstrates why “species lists” alone aren’t enough. Finding Aspergillus or Penicillium in a building does not automatically prove disease, because exposure dose, host susceptibility, and immune response determine clinical impact. But finding fungal DNA in sinus tissue and bacteria/fungi cultured from nasal secretions creates a more biologically coherent story—particularly when paired with imaging, ENT findings, and surgery.

The Infant and NF1: A Critical Causation Caution

The family later had an infant born with a “total body flare,” multiple café-au-lait spots, and a diagnosis of neurofibromatosis type 1 (NF1) at age 2.

It’s essential to be medically accurate here: NF1 is a genetic disorder caused by pathogenic variants in the NF1 gene, frequently inherited in an autosomal dominant pattern, and about half of cases occur due to de novo mutations.
Current medical genetics references do not implicate typical environmental exposures as a known cause of NF1 mutations.

So, even if prenatal mycotoxin exposure markers were detected (placenta/cord), that does not establish NF1 causation. The responsible way to interpret this portion of the narrative is:

  • The case raises questions about prenatal exposure pathways in water-damaged environments.
  • But NF1 itself remains fundamentally genetic, and any implied causal link would be speculative without extraordinary evidence.

What the Most Established Literature Says About Water-Damaged Buildings

Across large reviews and public health guidance, several findings are consistently supported:

Dampness and mold are linked to respiratory and allergic disease

The World Health Organization’s indoor air guidance on dampness and mold concludes that the most important observed effects are increased respiratory symptoms, allergies, and asthma.
NIOSH similarly summarizes damp building exposure risks: respiratory symptoms/infections, developing or worsening asthma, allergic rhinitis, eczema, and in some cases hypersensitivity pneumonitis.

There may be broader symptom associations, but evidence quality varies

Some newer reviews find associations between dampness/mold exposure and poorer mental health in adults across multiple studies—still with limitations in exposure measurement and confounding factors.
Experimental work has explored immune activation and neurologic effects following controlled mold exposures in animal models, offering plausible mechanisms, but translating these findings to human diagnosis requires caution.

Mycotoxins in humans: real chemistry, challenging interpretation

Mycotoxins exist and can be measured; OTA in breast milk and cord blood has been documented in scientific studies.
However, clinical interpretation—especially via urine tests marketed for “toxic mold exposure”—has been specifically criticized by public health authorities when tests are unvalidated for diagnosis.


What This Case Teaches Homeowners, Renters, and Clinicians

  1. Moisture is the root cause. If you control moisture quickly (dry within 24–48 hours, remove water-damaged porous materials, fix leaks, manage humidity), you dramatically reduce the chance of persistent microbial amplification.
  2. Health patterns matter. Clusters of chronic sinus symptoms, wheeze, cough, recurrent nosebleeds, fatigue, and cognitive complaints—especially when multiple occupants worsen in the same building—should prompt a serious look at indoor air quality and dampness.
  3. Evidence is strongest for the lungs and upper airways. The respiratory/allergic signal is the most robust in the literature.
  4. Advanced testing should be interpreted carefully. Tissue PCR and clinically indicated ENT diagnostics can be meaningful in the right context. Broad “mycotoxin panels,” especially urine-based tests used as stand-alone proof, deserve skepticism unless part of a rigorous medical and environmental evaluation.
  5. Animals can be sentinels. The dog’s extensive skin lesions with detected mycotoxins (as described) underscores that pets share exposures—often at floor level, close to dust reservoirs.

Bottom Line

Water-damaged buildings can generate complex microbial exposures—molds, bacteria, fragments, and by-products—that align strongly with respiratory and allergic illness patterns and may contribute to broader symptom clusters in some circumstances. The family case described here stands out because it attempted to connect building microbiology, clinical findings, and multi-matrix toxin detection, creating a richer (though still complex) picture than the typical “mold test + symptoms” story.

If you suspect a dampness problem, start with the fundamentals: identify and fix the moisture source, remove or properly remediate contaminated materials, and seek medically appropriate evaluation for symptoms—especially persistent sinus or asthma-like issues. And when interpreting toxin testing, weigh it against established public health guidance and validated clinical pathways.

Educational note: This article is informational and not medical advice. If you or your family have persistent symptoms, consult a licensed clinician for diagnosis and treatment, and a qualified building professional for moisture and remediation assessment.

Contact Aircheck Environmental to schedule a professional mold inspection & testing:

📞 Call/Text: (602) 935-6262

🗓️ Book online: https://aircheckenvironmental.com/contact-us/

⭐ View reviews on Google: https://maps.google.com/?cid=4340667973513633513

Scroll to Top